Long-Term Kidney Outcomes in Paediatric Osteosarcoma Survivors: A 20-Year Multi-Centre Study
Cancers · 28.04.2026 · 18 (9) · 1391
DOI: 10.3390/cancers18091391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 28.04.2026. Verfasst von Christy Yuen-Kwan Mak und 14 weiteren Autor:innen. Beteiligte Einrichtung: Haematology and Oncology Centre, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The long-term kidney outcomes in paediatric osteosarcoma survivors treated with nephrotoxic chemotherapeutic agents are not well-described.
Methods
We conducted a multi-centre retrospective cohort study and recruited paediatric osteosarcoma survivors who survived beyond 5 years from cancer diagnosis over a 20-year period. Chronic kidney disease (CKD) was defined as evidence of kidney impairment, chronic tubulopathy, and proteinuria upon last follow-up.
Results
We included 89 patients (57% males) with a mean follow-up period of 14.9 years. A total of 42 subjects (47.2%) developed CKD, 28 of whom had CKD stage 1 with either chronic tubulopathy or proteinuria; 14 patients had CKD stage 2 (eGFR < 90 mL/min/1.73 m2), while two had CKD stage 3 (eGFR < 60 mL/min/1.73 m2). Chronic tubular dysfunction was reported in 34 patients (38%), with hypomagnesemia being the most common manifestation. Proteinuria and hypertension were infrequently observed, in 3% and 8% of cases, respectively. We found that a history of severe AKI and aminoglycoside exposure during the treatment course were significant risk factors for CKD, but the dose-dependent relationships between the development of CKD and cisplatin, ifosfamide, and methotrexate could not be demonstrated.
Conclusions
CKD is prevalent among paediatric osteosarcoma survivors. Caution is needed when using multiple nephrotoxic agents at the same time, as this could increase the risk of CKD in the long run. Multi-disciplinary regular surveillance should be performed to identify and manage CKD early, including kidney function, electrolyte, and proteinuria monitoring.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Haematology and Oncology Centre, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong SAR, China.
- Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
- Neuro-Oncology Section, Hospital for Sick Children, Toronto, ON M5G1E8, Canada.
- Department of Paediatrics, Prince of Wales Hospital, Hong Kong SAR, China.
- Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong SAR, China.
- Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Christy Yuen-Kwan Mak, Dennis Tak-Loi Ku, Jeffrey Ping-Wa Yau, Evelyn Ruoyun Lu, Matthew Ming-Kong Shing, Desmond Yat-Hin Yap
Zitieren
APA
Mak, C. Y., Ku, D. T., Liu, A. P., Lee, V., Yau, J. P., Fu, E. C., Lu, E. R., Shing, M. M., Ho, I. Y., Pak, W. W., Yap, D. Y., Leung, A. W., Cheng, F. W., Ma, A. L., & Chan, E. Y. (2026). Long-Term Kidney Outcomes in Paediatric Osteosarcoma Survivors: A 20-Year Multi-Centre Study. Cancers, 18(9), 1391. https://doi.org/10.3390/cancers18091391
Vancouver
Mak CY, Ku DT, Liu AP, Lee V, Yau JP, Fu EC, et al. Long-Term Kidney Outcomes in Paediatric Osteosarcoma Survivors: A 20-Year Multi-Centre Study. Cancers. 2026;18(9):1391. doi:10.3390/cancers18091391
BibTeX
@article{Mak2026,
author = {Mak, Christy Yuen-Kwan and Ku, Dennis Tak-Loi and Liu, Anthony Pak-Yin and Lee, Vincent and Yau, Jeffrey Ping-Wa and Fu, Eric Chun-Ho and Lu, Evelyn Ruoyun and Shing, Matthew Ming-Kong and Ho, Irene Yuk-Ying and Pak, Will Wai-Lun and Yap, Desmond Yat-Hin and Leung, Alex Wing-Kwan and Cheng, Frankie Wai-Tsoi and Ma, Alison Lap-Tak and Chan, Eugene Yu-Hin},
title = {Long-Term Kidney Outcomes in Paediatric Osteosarcoma Survivors: A 20-Year Multi-Centre Study},
journal = {Cancers},
year = {2026},
volume = {18},
number = {9},
pages = {1391},
doi = {10.3390/cancers18091391}
}
EUVIMED